Breast cancer
Results
Phase 3
This trial looked at a drug called everolimus alongside trastuzumab (Herceptin) and chemotherapy for breast cancer that has spread to another part of the body. The trial was for women with breast cancer that has large amounts of the protein (HER2 positive).
Recruitment start: 26 October 2009
Recruitment end: 23 May 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Perren
Experimental Cancer Medicine Centre (ECMC)
National Institute for Health Research Cancer Research Network (NCRN)
Novartis
Last reviewed: 04 Aug 2016
CRUK internal database number: 4157